Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma,Cancer Biology & Therapy

当前位置： X-MOL 学术 › Cancer Biol. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma
Cancer Biology & Therapy ( IF 3.6 ) Pub Date : 2024-02-07 , DOI: 10.1080/15384047.2024.2312602
Kazuyuki Numakura ₁ , Ryoma Igarashi ₁ , Makoto Takahashi ₁ , Taketoshi Nara ₁ , Sohei Kanda ₁ , Mitsuru Saito ₁ , Shintaro Narita ₁ , Takamitsu Inoue ₁ , Takenori Niioka ₂ , Masatomo Miura ₃ , Tomonori Habuchi ₁

Affiliation

Axitinib is an oral multi-target tyrosine kinase inhibitor used for the treatment of renal cell carcinoma (RCC). Because of the severe adverse events (AEs) associated with axitinib, patients often ...

更新日期：2024-02-10

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>